Renovo

Acellular dermal matrix/wound care for treatment of chronic wounds and soft tissue defects in horses. Acellular dermal matrix or bioactive wound care product. Mechanism: provides extracellular matrix scaffold (collagen, glycosaminoglycans) that supports fibroblast migration and proliferation, angiogenesis, and organized tissue regeneration for treatment of chronic or deep wounds in horses. Scaffold is remodeled into functional tissue. Key information Equine joint/HA product. Refrigerate. Intra-articular injection. Strict aseptic technique. Single-use.

Wound application: apply per product-specific protocol. Aseptic technique during placement. Store at room temperature; protect from light. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

Expected local inflammatory response during scaffold integration. Infection risk if wound not managed aseptically. Rare: hypersensitivity to matrix components. Generally well tolerated.

For animals For wound management — follow wound care protocol. Aseptic technique during application. For people handling this medication Wear gloves when handling. Wash hands thoroughly with soap and water after handling. Wound scaffold — Injectable — administered by veterinary staff only. Wash hands thoroughly with soap and water after handling. If accidentally self-injected, seek emergency medical attention immediately. Wear gloves when applying.

Contact your veterinarian. HA joint product — overdose managed by veterinary staff.